Zum Inhalt springen Zur Suche springen

News-Detail

Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trial.
Kutzsche et al., Nat Commun. 2025

Janine Kutzsche, Nicoleta Carmen Cosma, Gunther Kauselmann, Friederike Fenski, Christine Bieniek, Tuyen Bujnicki, Marlene Pils, Oliver Bannach, Dieter Willbold, Oliver Peters.

Oral PRI-002 treatment in patients with MCI or mild AD: a randomized, double-blind phase 1b trial.

Nat Commun. 2025 May 6;16(1):4180. doi: 10.1038/s41467-025-59295-z. PubMed ID: 40324978

 

Further Information:

PubMed

Dieter Willbold

Kategorie/n: NND-Publikationen